đź”´ Day 1 Live Update
We are currently highlighting an important presentation from Dr. Anil Koul, PhD, Professor of Translational Discovery at the London School of Hygiene and Tropical Medicine, London, United Kingdom.
His presentation, “Discovery of New Antibiotic – JNJ6640 – for TB Treatment: Next Generation beyond Bedaquiline,” is part of Session I: Drug Resistance Mechanisms and Antibiotic Discovery.
The session focuses on the discovery of JNJ6640 and its relevance to the continuing search for new approaches in tuberculosis drug discovery and treatment.
Dr. Koul’s presentation contributes to a broader scientific discussion on developing new therapeutic options for tuberculosis and addressing the challenges associated with existing treatment approaches.
The scientific discussions continue throughout Day 1 of Frontiers in TB & Mycobacteriology 2026, bringing together researchers and experts working across tuberculosis, mycobacteriology, drug discovery, antimicrobial resistance, and related areas.
This conference is organized by Impact Research Communications (IRC)
More info: https://tb.ircconferences.net/ | Frontiers in TB & Mycobacteriology
